Graves' Ophthalmopathy: VISA versus EUGOGO Classification, Assessment, and Management

Area of Science:

• Ophthalmology
• Endocrinology
• Immunology

Background:

• Graves' ophthalmopathy (GO) is an autoimmune inflammatory disorder affecting eye and orbital tissues, linked to thyroid disease.
• GO presents with an active phase followed by regression, with a small percentage experiencing severe, sight-threatening complications.
• Accurate assessment of GO severity and activity is crucial for effective treatment decisions.

Purpose of the Study:

• To critically analyze existing classification and assessment systems for Graves' ophthalmopathy.
• To propose a simplified "GO activity assessment checklist" for clinical practice.
• To review current treatments and provide management guidelines, including emerging therapeutic options.

Main Methods:

• Review of current literature on Graves' ophthalmopathy classification, assessment, and management.
• Analysis of the VISA and EUGOGO grading systems.
• Discussion of established and novel treatment modalities.

Main Results:

• Existing grading systems like VISA and EUGOGO are widely used but can be complex.
• A simplified "GO activity assessment checklist" is proposed for routine clinical use.
• Current treatments are reviewed, with guidelines provided based on disease severity and activity.

Conclusions:

• Effective management of Graves' ophthalmopathy hinges on accurate disease assessment.
• The proposed checklist aims to streamline clinical evaluation.
• Emerging therapies, including monoclonal antibodies and immunomodulatory agents, offer promising future treatment avenues for GO.